newsfilter
← Latest News
GlobeNewswire·

Allena Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Business Update

-- Expanding URIROX-2 Trial Sites; Interim Analysis on Track for the First Quarter of 2022 –- -- Initiated Phase 1 Clinical Trial of ALLN-346; Initial Data Expected in the Fourth Quarter of...